Research

IN THIS SECTION 1. Overview 2. Research Focus 3. Projects 4. Publications

 

Publications

 

1988-1989

1989

Borer JS, Kuschnir E.  Nuclear Cardiology Valvulopathies (Cardiologia Nuclear).  M Valvulopatias:  Conceptos Actuales, de la Riva J, Martinez F, eds, Universidad National de Cordoba and Laboratorio Roemmers, (Cordova), 1989, pp. 92-98.

Wackers FJTh, Terrin ML, Kayden DS, Knatterud G, Forman S, Braunwald E, Zaret BL and the TIMI Investigators (incl. Borer JS).  Quantitative radionuclide assessment of regional ventricular function after thrombolytic therapy for acute myocardial infarction: results of Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial.  Journal of the American College of Cardiology 1989;13:998-1005.

Rogers WJ, Bourge RC, Papapietro SE, Wackers FJTh, Zaret BL, Forman S, Dodge HT, Robertson TL, Passamani ER, Braunwald E, for the TIMI Investigators (incl. Borer JS). Variables predictive of good functional outcome following thrombolytic therapy in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Pilot Study.  American Journal of Cardiology 1989;63:503-512.

Gerling B, Gottdiener J, Borer JS.  Cardiovascular complications of the treatment of Hodgkin's disease, in Hodgkin's Disease:  The Consequences of Survival (Lacher and Redman, eds.) Lea and Febiger: Philadelphia, 1989, pp. 267-295.

Roman MJ, Klein L, Devereux RB, Kligfield P, Niles NW, Hochreiter C, Isom OW, Borer JS.  Reversal of left ventricular dilatation, hypertrophy, and dysfunction by valve replacement in aortic regurgitation.  American Heart Journal 1989;118:553-563.

Borer JS, Kuschnir E.  Thrombolytic therapy:  the dilemma of choice.  Revista de la Federacion Argentina de Cardiologia 1989;18:173-179.

Borer JS.  Prognostication strategies in heart failure and valvular heart diseases:  current concepts and their support, in Annual of Cardiac Surgery, 1989, Yacoub M, ed., Current Science, Ltd: London,1989, pp. 115-124.

Roman MJ, Devereux RB, Atlas SA, Pini R, Ganau A, Hochreiter C, Niles NW, Borer JS, Laragh JH.  Relationship of atrial natriuretic factor to left ventricular volume and mass. American Heart Journal 1989;118:1236-1242.

Kenet RO, Herrold EM, Goldberg HL, Borer JS.  Digital subtraction ventriculography for diagnosing coronary artery disease:  I. Exercise, in Cardiac Applications of Digital Angiography (Wasserman AG, Ross AM, eds.) Futura: Mount Kisco, 1989, pp. 61-72.

Chaitman BR, Thompson B, Wittry MD, Stump D, Hamilton WP, Hillis LD, Dwyer JG, Solomon RE, Knatterud GL, for the TIMI Investigators (incl. Borer JS).  The use of tissue-type plasminogen activator for acute myocardial infarction in the elderly:  results from Thrombolysis in Myocardial Infarction Phase I, Open Label Studies and the Thrombolysis in Myocardial Infarction Phase II Pilot Study.  Journal of the American College of Cardiology 1989;14:1159-1165.

1988

Frye RL, Higgins MW, Beller GA, Benson JA, Borer JS, Curry CL, Gersh BJ, Goldman L, Klocke FJ, Savage DD, Williams JF.  Major demographic and epidemiologic trends affecting adult cardiology.  Task Force III, 19th Bethesda Conference, Trends in the Practice of Adult Cardiology:  Implications for Manpower. Journal of American College of Cardiology 1988;12:829-831.

Magid NM, Young MS, Wallerson DC, Goldweit RS, Carter JN, Devereux RB, Borer JS. Hypertrophic and functional response to experimental chronic aortic regurgitation. Journal of Molecular and Cellular Cardiology 1988;20:239-246.

Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B, and Co-Investigators (including Borer JS).  The effect of intravenous thrombolytic therapy on left ventricular function:  a report of tissue-type plasminogen activator and streptokinase from the thrombolysis in myocardial infarction (TIMI Phase I) Trial.  Circulation, AHA Focus Series 1988;2:40-52.

Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, Bell WR, Knatterud G, Robertson TL, Terrin ML, for the TIMI Investigators (including Borer JS).  Thrombolysis in myocardial infarction (TIMI) trial - Phase I:  Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase.  Journal of the American College of Cardiology 1988;11:1-11.

Okin PM, Kligfield P, Ameisen O, Goldberg HL, Borer JS.  Identification of anatomically extensive coronary artery disease by the exercise ECG ST segment/heart rate slope. American Heart Journal 1988;115:1002-1013.

Blake J, Devereux RB, Herrold EM, Jason M, Fisher J, Borer JS, Laragh JH.  Relation of concentric left ventricular hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in established essential hypertension.  American Journal of Cardiology 1988;62:246-252.

Kenet RO, Herrold EM, Tearney GJ, Wong KK, Hill JP, Borer JS.  3-D Quantitative assessment of coronary luminal morphology using biplane digital angiography.  Computers in Cardiology (IEEE  #0276-6574/89) 1988:13-17.

Pini R, Devereux RB, Greppi B, Roman MJ, Hochreiter C, Kramer-Fox R, Niles NW, Kligfield P, Erlebacher JA, Borer JS.  Comparison of mitral valve dimensions and motion in mitral valve prolapse with severe mitral regurgitation to uncomplicated mitral valve prolapse and to mitral regurgitation without mitral valve prolapse.  American Journal of Cardiology 1988;62:257-263.

Dalen JE, Gore JM, Braunwald E, Borer J, Goldberg RJ, Passamani ER, Forman S, Knatterud G, and the TIMI Investigators.  Six- and twelve-month followup of the Phase I Thrombolysis in Myocardial Infarction (TIMI) Trial.  American Journal of Cardiology 1988;62:179-185.

 

< Prev

Next >